Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive Breast Cancer: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis

PURPOSE: Pyrotinib is a newly-developed irreversible pan-ErbB receptor tyrosine kinase inhibitor. This study reported the first real-world data of pyrotinib-based therapy in metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC), focusing on efficacy in lapatinib-trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ying, Lin, Mingxi, Zhang, Jian, Wang, Biyun, Tao, Zhonghua, Du, Yiqun, Zhang, Sheng, Cao, Jun, Wang, Leiping, Hu, Xichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577809/
https://www.ncbi.nlm.nih.gov/pubmed/32340083
http://dx.doi.org/10.4143/crt.2019.633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577809/
https://www.ncbi.nlm.nih.gov/pubmed/32340083
http://dx.doi.org/10.4143/crt.2019.633

Ejemplares similares